FIELD: pharmacology.
SUBSTANCE: group of inventions is a protective agent for cornea and conjunctiva, as well as a suppressant in case of keratoconjunctival disorder, comprising glycosylglycerin as an active ingredient, wherein the glycosylglycerin comprises at least one glycosylglycerin selected from the group consisting of 1-glyceryl glycosideα,αββ 2-glyceryl glycoside, 1-glyceryl glycoside and 2-glyceryl glycoside, and where the agent is used to protect the conjunctiva and cornea in case of Sjogren's syndrome, Stevens-Johnson syndrome, dry eye syndrome, exogenous disease caused by a postoperative condition, drug, damage or contact lens wear; and application of the said glycosylglycerin for preparation of a drug for conjunctiva and cornea protection and keratoconjunctival disorder suppression; as well as a method for cornea and conjunctiva protection and keratoconjunctival disorder suppression, comprising administration of the said glycosylglycerin.
EFFECT: invention provides allergic symptoms relief.
6 cl, 3 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
PREVENTIVE OR THERAPEUTIC AGENT FOR TREATMENT OF KERATOCONJUCTIVAL DISORDERS | 2006 |
|
RU2406499C2 |
THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS | 2013 |
|
RU2659203C2 |
OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
THERAPEUTIC RECOVERY AND ENHANCEMENT OF OCULAR SURFACE WETTING | 2009 |
|
RU2510274C2 |
THERAPEUTIC AGENT FOR DRY EYE, CHARACTERIZED BY EYE APPLICATION OF DRY EYES, WEARING FLEXIBLE CONTACT LENSES | 2016 |
|
RU2742032C2 |
EXCITER OF NEURITES FORMATION | 2008 |
|
RU2442582C2 |
THERAPEUTIC MEDICATION AGAINST KERATOCONJUNCTIVAL DISTURBANCE | 2006 |
|
RU2420280C2 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
COMPOSITIONS CONTAINING ANAKINRA | 2016 |
|
RU2728795C2 |
Authors
Dates
2017-09-11—Published
2012-11-22—Filed